Gilead Sciences, Inc. (BVMF:GILD34)
Brazil · Delayed Price · Currency is BRL 333.02
0.00 (0.00%)
At close: Dec 2, 2025
Gilead Sciences Market Cap
Gilead Sciences has a market cap or net worth of 806.12 billion as of December 4, 2025. Its market cap has increased by 26.23% in one year.
Market Cap
806.12B
Enterprise Value
882.22B
Revenue
155.02B
Ranking
n/a
PE Ratio
18.65
Stock Price
333.02
Market Cap Chart
Since January 22, 1992, Gilead Sciences's market cap has increased from 240.84M to 806.12B, an increase of 334,611.10%. That is a compound annual growth rate of 27.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 3, 2025 | 822.45B | 15.51% |
| Dec 31, 2024 | 711.99B | 45.36% |
| Dec 29, 2023 | 489.80B | -13.96% |
| Dec 30, 2022 | 569.24B | 12.17% |
| Dec 31, 2021 | 507.47B | 33.81% |
| Dec 31, 2020 | 379.26B | 14.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rede D'Or São Luiz | 101.09B |
| Raia Drogasil | 41.21B |
| Hypera | 16.96B |
| Fleury | 8.28B |
| Odontoprev | 6.42B |
| Diagnósticos da América | 4.37B |
| Empreendimentos Pague Menos | 4.01B |
| Blau Farmacêutica | 2.38B |